Ionis Pharmaceuticals has seen its share price slide sharply in 2026, which puts fresh attention on whether the current valuation is still in line with what its sales can support. With sentiment now ...
Source LinkIonis Pharmaceuticals has seen its share price slide sharply in 2026, which puts fresh attention on whether the current valuation is still in line with what its sales can support. With sentiment now ...
Source Link
Comments